Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Pharmaceutical Executive Europe  E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked 40 pharma leaders, what's your company's most pressing concern?

Attracting and retaining talent 38%
Pricing and reimbursement issues 31%
Regulatory issues 23%
Pipeline 8%

Talk to us:
editor@pharmexeceurope.com

Advertise with us: mgoodrich@advanstar.com

17 April, 2012
In this Issue
A New Agenda for the Emerging Markets
Pharm Exec talks to India's most prominent scientist, Dr R.A. Mashelkar, about setting a new agenda for pharma in emerging markets Read more...
2012: Outsourcing: Ways to Recover Lost Margins
Although there is sales growth in exciting new global markets, these markets simply cannot command the high-priced drugs of the past. Granted, the potential exists for significantly increased sales volume over time, but the increased sales will be at a lower price and at lower margins, writes Greg Brandyberry. More...
Scotland, Independence and Pharma
What does a Scottish vote for independence mean for Big Pharma investment and healthcare funding and delivery in the UK? More...
Marketers: Think Digital First
According to a recent study, only 9 percent of senior-level marketers think that traditional ad agencies are doing a good job of evolving their capabilities for the digital age. Bill Drummy lays out the case of why a digital-first approach to pharma marketing is dramatically more effective than traditional marketing. More...
Also in this issue…
Navigating M&A Complexities
New Opportunities for Market Order and Growth in China
Pharm Exec Ad Stars 2012